help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 24, 2004
Endocrinology, doi:10.1210/en.2003-1479
A more recent version of this article appeared on July 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/7/3395    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DELBÈS, G.
Right arrow Articles by HABERT, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DELBÈS, G.
Right arrow Articles by HABERT, R.

Submitted on October 31, 2003
Accepted on March 15, 2004

ER{beta}-mediated inhibition of male germ cell line development in mice by endogenous estrogens during perinatal life*

Géraldine DELBÈS, Christine LEVACHER*, Catherine PAIRAULT, Chrystèle RACINE, Clotilde DUQUENNE, Andrée KRUST, and René, HABERT

1-Unité de Gamétogenèse et génotoxicité., INSERM U566 - CEA - Université Paris 7- Denis Diderot, 92265 Fontenay-aux-Roses, France; 2- IGBMC - INSERM U184, CNRS/INSERM/ULP, Collège de France, BP 163, 37404 Illkirch-Cedex, France.

* To whom correspondence should be addressed. E-mail: christine.levacher{at}cea.fr.

Epidemiological, clinical and experimental studies have suggested that excessive exposure to estrogens during fetal/neonatal life can lead to reproductive disorders and sperm abnormalities in adulthood. However, it is unknown whether endogenous concentrations of estrogens affect establishment of the male fetal germ cell lineage. We addressed this question by studying the testicular development of mice in which the ER{beta} or the ER{alpha} gene was inactivated. The homozygous inactivation of ER{beta} (ER{beta}-) increased the number of gonocytes by 50% in two- and six-day-old neonates. The numbers of Sertoli and Leydig cells and the level of testicular testosterone production were unaffected, suggesting that estrogens act directly on the gonocytes. The increase in the number of gonocytes did not occur during fetal life, but instead occurred just after birth, when gonocytes resumed mitosis and apoptosis. It seems to result from a decrease in apoptosis rate evaluated by TUNEL method and cleaved caspase-3 immunohistochemical detection. Lastly, mice heterozygous for the ER{beta} gene inactivation behaved similarly to their ER{beta}- littermates in terms of the number of gonocytes, apoptosis and mitosis, suggesting that these cells are highly sensitive to the binding of estrogens to ER{beta}. ER{alpha} inactivation had no effect on the number of neonatal gonocytes and Sertoli cells. In conclusion, this study provides the first demonstration that endogenous estrogens can physiologically inhibit germ cell growth in the male. This finding may have important implications concerning the potential action of environmental estrogens.


Key words: Estrogen receptor • gonocyte • apoptosis • testicular development




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Weiss, M. L. Bernhardt, M. M. Laronda, L. A. Hurley, C. Glidewell-Kenney, S. Pillai, M. Tong, K. S. Korach, and J. L. Jameson
Estrogen Actions in the Male Reproductive System Involve Estrogen Response Element-Independent Pathways
Endocrinology, December 1, 2008; 149(12): 6198 - 6206.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Sirianni, A. Chimento, C. Ruggiero, A. De Luca, R. Lappano, S. Ando, M. Maggiolini, and V. Pezzi
The Novel Estrogen Receptor, G Protein-Coupled Receptor 30, Mediates the Proliferative Effects Induced by 17{beta}-Estradiol on Mouse Spermatogonial GC-1 Cell Line
Endocrinology, October 1, 2008; 149(10): 5043 - 5051.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Montani, M. Penza, M. Jeremic, G. Biasiotto, G. La Sala, M. De Felici, P. Ciana, A. Maggi, and D. Di Lorenzo
Genistein is an Efficient Estrogen in the Whole-Body throughout Mouse Development
Toxicol. Sci., May 1, 2008; 103(1): 57 - 67.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Bouskine, M. Nebout, B. Mograbi, F. Brucker-Davis, C. Roger, and P. Fenichel
Estrogens Promote Human Testicular Germ Cell Cancer through a Membrane-Mediated Activation of Extracellular Regulated Kinase and Protein Kinase A
Endocrinology, February 1, 2008; 149(2): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. F.G Lucas, E. R Siu, C. A Esteves, H. P Monteiro, C. A Oliveira, C. S Porto, and M. F. M Lazari
17Beta-Estradiol Induces the Translocation of the Estrogen Receptors ESR1 and ESR2 to the Cell Membrane, MAPK3/1 Phosphorylation and Proliferation of Cultured Immature Rat Sertoli Cells
Biol Reprod, January 1, 2008; 78(1): 101 - 114.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. R. Cederroth, O. Schaad, P. Descombes, P. Chambon, J.-D. Vassalli, and S. Nef
Estrogen Receptor {alpha} Is a Major Contributor to Estrogen-Mediated Fetal Testis Dysgenesis and Cryptorchidism
Endocrinology, November 1, 2007; 148(11): 5507 - 5519.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. Delbes, C. Duquenne, J. Szenker, J. Taccoen, R. Habert, and C. Levacher
Developmental Changes in Testicular Sensitivity to Estrogens throughout Fetal and Neonatal Life
Toxicol. Sci., September 1, 2007; 99(1): 234 - 243.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M L Gould, P R Hurst, and H D Nicholson
The effects of oestrogen receptors {alpha} and {beta} on testicular cell number and steroidogenesis in mice
Reproduction, August 1, 2007; 134(2): 271 - 279.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Boukari, M. L. Ciampi, A. Guiochon-Mantel, J. Young, M. Lombes, and G. Meduri
Human fetal testis: source of estrogen and target of estrogen action
Hum. Reprod., July 1, 2007; 22(7): 1885 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Merlet, C. Racine, E. Moreau, S. G. Moreno, and R. Habert
Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation
PNAS, February 27, 2007; 104(9): 3615 - 3620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Kress, C. Gautier-Courteille, H. B. Osborne, C. Babinet, and L. Paillard
Inactivation of CUG-BP1/CELF1 Causes Growth, Viability, and Spermatogenesis Defects in Mice
Mol. Cell. Biol., February 1, 2007; 27(3): 1146 - 1157.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. Assinder, R. Davis, M. Fenwick, and A. Glover
Adult-only exposure of male rats to a diet of high phytoestrogen content increases apoptosis of meiotic and post-meiotic germ cells
Reproduction, January 1, 2007; 133(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
G. Delbes, C. Levacher, and R. Habert
Estrogen effects on fetal and neonatal testicular development.
Reproduction, October 1, 2006; 132(4): 527 - 538.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
C Roger, S Lambard, A Bouskine, B Mograbi, D Chevallier, M Nebout, G Pointis, S Carreau, and P Fenichel
Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor {beta} and aromatase
J. Mol. Endocrinol., August 1, 2005; 35(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. A. Arreguin-Arevalo and T. M. Nett
A Nongenomic Action of 17{beta}-Estradiol as the Mechanism Underlying the Acute Suppression of Secretion of Luteinizing Hormone
Biol Reprod, July 1, 2005; 73(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Delbes, C. Levacher, C. Duquenne, C. Racine, P. Pakarinen, and R. Habert
Endogenous Estrogens Inhibit Mouse Fetal Leydig Cell Development via Estrogen Receptor {alpha}
Endocrinology, May 1, 2005; 146(5): 2454 - 2461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society